ArticleHealth science reports2025
A Wake-Up Call: Can Africa Sustain HIV/AIDS Programs Without Foreign Aid?
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A designathon to collaboratively develop sustainable HIV prevention services for youth with community-based organizations in Nigeria.PloS one · 2026Article
- The successful scaling-up of antiretroviral therapy globally has many lessons for advancing universal health coverage: progress at risk.Globalization and health · 2025Article
- A Wake-Up Call: Can Africa Sustain HIV/AIDS Programs Without Foreign Aid?Health science reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Africa's HIV/AIDS response has historically depended on substantial foreign aid from initiatives such as PEPFAR, the Global Fund, and USAID. These programs have dramatically expanded access to antiretroviral therapy (ART), reducing mortality and transmission rates. However, with increasing uncertainty in global funding, the continent faces a pressing question: Can Africa sustain HIV/AIDS programs independently? This study investigates the implications of foreign aid withdrawal and explores sustainable strategies for the future of HIV/AIDS care on the continent. Methods: This study involved a critical review and synthesis of peer-reviewed literature, global health databases (WHO, UNAIDS), and policy documents focusing on foreign aid's role in African HIV/AIDS programs. We conducted a comparative case analysis, using Botswana as a model for successful domestic financing, and evaluated potential fiscal strategies and integration into Universal Health Coverage (UHC). Results: Evidence shows that sudden foreign aid reductions have disrupted ART access, increased viral load and transmission rates, and reversed decades of health gains. Donor-dependent nations reported fragmented care systems and decreased resilience. Conversely, Botswana's model-marked by diversified revenue sources, strong governance, and UHC integration-demonstrated resilience to funding fluctuations. Innovative fiscal measures such as sin taxes, private-sector partnerships, and integrated national financing frameworks emerged as viable tools for sustainability. However, challenges persist, including political instability, weak governance, and economic fragility. Conclusion: Foreign aid remains a critical lifeline, but Africa must urgently shift toward self-reliant HIV/AIDS programs. Strengthening domestic financing, enhancing governance, leveraging public-private partnerships, and embedding HIV care into UHC are key pillars for sustainability. African governments must act decisively to future-proof health systems against donor volatility and ensure uninterrupted access to life-saving treatment for millions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.